Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress
Main Content

Parallel Session 3412

Atypical Parkinsonism Revisited: PSP, CBS, MSA and Beyond

Tuesday, October 7, 2025
16:30 - 18:00 | Room TBD

In this session, the faculty will present clinical and Imaging Heterogeneity and current and future treatment of PSP, CBS and MSA.


Chairs:

Han-Joon Kim, South Korea
Wassilios Meissner, France

Presenters:

Diagnostic Approach
Edwin Jabbari, United Kingdom

Approach to Management
Ikuko Aiba, Japan

Disease Modifying Trials
Irene Litvan, USA

CSPC Liaisons:

Han-Joon Kim, South Korea
Maria Stamelou, Greece

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Provide a clinical diagnostic approach to a patient with red-flags suggestive of atypical parkinsonism
  2. Discuss pharmacologic and non-pharmacologic management in atypical parkinsonism
  3. Discuss recent and ongoing disease modifying trials in atypical parkinsonism

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Industry
Researcher / Basic Science

Education Level

Advanced / Expert
Beginner / Foundational
Intermediate / Experienced

Focus

Clinical